Funder
Hundred Talents Program of Sun Yat-Sen University
Guangdong Basic and Applied Basic Research Foundation
Shenzhen Science and Technology Program
Publisher
Springer Science and Business Media LLC
Reference89 articles.
1. Overview of Diabetes. Available from: https://www.who.int/health-topics/diabetes/diabetes#tab=tab_1.
2. Perry CM. Liraglutide: a review of its use in the management of type 2 diabetes mellitus. Drugs. 2011;71(17):2347–73.
3. Dumont C, Beloqui A, Miolane C, Bourgeois S, Préat V, Fessi H, Jannin V. Solid lipid nanocarriers diffuse effectively through mucus and enter intestinal cells – but where is my peptide? Int J Pharm. 2020;586:119581.
4. Meece J. Pharmacokinetics and pharmacodynamics of liraglutide, a long-acting, potent glucagon-like peptide-1 analog. Pharmacotherapy. 2009;29(12 Pt 2):33S-42S.
5. Tran KL, Park YI, Pandya S, Muliyil NJ, Jensen BD, Huynh K, Nguyen QT. Overview of glucagon-like peptide-1 receptor agonists for the treatment of patients with type 2 diabetes. Am Health Drug Benefits. 2017;10(4):178–88.